Pathology Department, Global Safety Assessment, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK.
Int J Exp Pathol. 2010 Jun;91(3):288-301. doi: 10.1111/j.1365-2613.2010.00713.x. Epub 2010 Apr 1.
Assessment of the histopathological and plasma biochemical characteristics of diabetic and non-diabetic rat strains [Han and AP Wistar, lean and obese Zucker Fatty (ZF), and lean and obese Zucker Diabetic Fatty (ZDF) rats] was performed at 6 or 14 weeks of age. Wistar and lean ZF and ZDF rats showed no or minimal islet pathology or plasma biochemical alterations at both timepoints. Obese ZFs were euglycaemic at both timepoints and mildly and severely hyperinsulinaemic at 6 and 14 weeks respectively. Islet morphology was normal at 6 weeks but at 14 weeks, islet hyperplasia was present with a minority showing degenerative changes namely, beta-cell vacuolation, vascular congestion and haemorrhage with minimal mononuclear cell and T lymphocytic infiltration. Obese ZDFs were euglycaemic and moderately hyperinsulinaemic at 6 weeks and severely hyperglycaemic with minor hypoinsulinaemia at 14 weeks. Obese ZDFs at 6 weeks showed mainly normal islets with some displaying degeneration (ranging from beta-cell vacuolation alone to the features described above). At 14 weeks, islet degeneration was more severe and widespread: beta-cell death was present in numerous islets at low level. Islet beta-cell numbers were reduced or absent (with associated reduction in insulin immunostaining) within the islets that now consisted predominantly of fibroblasts, collagen and mononuclear cells. Fibroproliferation consisting of smooth muscle actin-alpha-positive tissue was associated with mononuclear cell infiltration. Some fibrous scars were visible indicative of lost islets. Islet degeneration in obese ZF and ZDF rats was not accompanied by a reduction in beta-cell proliferation or in compensatory proliferation of beta-cell neogenic clusters. In the light of recent reports of adaptive and inflammation-mediated degenerative changes in human non-insulin dependent diabetes mellitus (NIDDM) islets, the hypertrophy/hyperplasia of beta-cells and islet degeneration involving infiltration by monocyte/macrophages in obese ZF and obese ZDF rats respectively offers substantial potential for elucidation of the processes involved.
评估了糖尿病和非糖尿病大鼠品系[汉和 AP 白化 Wistar、瘦型和肥胖型 Zucker 肥胖(ZF)以及瘦型和肥胖型 Zucker 糖尿病肥胖(ZDF)大鼠]的组织病理学和血浆生化特征,分别在 6 周和 14 周龄时进行。Wistar 和瘦型 ZF 和 ZDF 大鼠在这两个时间点均未出现或仅出现最小程度的胰岛病理学或血浆生化改变。肥胖型 ZF 在这两个时间点均为血糖正常,分别在 6 周和 14 周时轻度和重度高胰岛素血症。6 周时胰岛形态正常,但 14 周时出现胰岛增生,少数表现出退行性变化,即β细胞空泡化、血管充血和出血,伴有最小程度的单核细胞和 T 淋巴细胞浸润。肥胖型 ZDF 在 6 周时血糖正常,中度高胰岛素血症,14 周时轻度低血糖。肥胖型 ZDF 在 6 周时主要显示正常胰岛,一些胰岛出现退化(从单纯的β细胞空泡化到上述特征)。14 周时,胰岛退行性变更加严重和广泛:在许多胰岛中出现β细胞死亡,水平较低。胰岛β细胞数量减少或缺失(同时胰岛素免疫染色减少),现在胰岛主要由成纤维细胞、胶原和单核细胞组成。成纤维细胞增殖,伴有平滑肌肌动蛋白-α阳性组织,与单核细胞浸润有关。一些纤维性瘢痕可见,提示胰岛丢失。肥胖型 ZF 和 ZDF 大鼠的胰岛退行性变不伴有β细胞增殖减少或β细胞新生簇的代偿性增殖。鉴于最近关于人类非胰岛素依赖型糖尿病(NIDDM)胰岛适应性和炎症介导的退行性变化的报道,肥胖型 ZF 和肥胖型 ZDF 大鼠的β细胞肥大/增生和胰岛退行性变,分别伴有单核细胞/巨噬细胞浸润,为阐明相关过程提供了很大的潜力。